Lobby organisation
Daiichi Sankyo Europe GmbH
Company · Health & pharma · HQ: Germany · Transparency Register entry
As of 7 November 2026, Daiichi Sankyo Europe GmbH appears in 8 declared MEP meetings (8 different MEPs), most often with European People's Party.
In their own words
“Daiichi Sankyo is a research-based global pharmaceutical company headquartered in Japan with operations in more than 20 countries worldwide. The European headquarters are located in Munich; mainly active in the areas of cardiovascular diseases & oncology.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 8 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2026. Bar length is relative to its busiest year (5 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 8 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 9 Sep 2026 | Oliver Schenk | Industrielle Gesundheitswirtschaft in der EU |
| 12 May 2026 | Margarita de la Pisa Carrión | SANT COMMITTEE ONGOING WORK |
| 12 May 2026 | Elena Nevado del Campo | Oncology updates |
| 18 Nov 2025 | Michele Picaro | Health |
| 3 Jul 2025 | Hildegard Bentele | Industry Policy |
| 28 Mar 2025 | Angelika Niebler | German and EU Health Policy |
| 25 Mar 2025 | Stine Bosse | European health policy |
| 17 Feb 2025 | Sirpa Pietikäinen | Women's health |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.